1. Home
  2. PDI vs RGEN Comparison

PDI vs RGEN Comparison

Compare PDI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDI
  • RGEN
  • Stock Information
  • Founded
  • PDI 2012
  • RGEN 1981
  • Country
  • PDI United States
  • RGEN United States
  • Employees
  • PDI N/A
  • RGEN N/A
  • Industry
  • PDI Trusts Except Educational Religious and Charitable
  • RGEN Medical/Dental Instruments
  • Sector
  • PDI Finance
  • RGEN Health Care
  • Exchange
  • PDI Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • PDI 7.3B
  • RGEN 6.6B
  • IPO Year
  • PDI N/A
  • RGEN N/A
  • Fundamental
  • Price
  • PDI $19.21
  • RGEN $124.35
  • Analyst Decision
  • PDI
  • RGEN Buy
  • Analyst Count
  • PDI 0
  • RGEN 9
  • Target Price
  • PDI N/A
  • RGEN $167.38
  • AVG Volume (30 Days)
  • PDI 1.5M
  • RGEN 1.0M
  • Earning Date
  • PDI 01-01-0001
  • RGEN 07-29-2025
  • Dividend Yield
  • PDI 13.81%
  • RGEN N/A
  • EPS Growth
  • PDI N/A
  • RGEN N/A
  • EPS
  • PDI N/A
  • RGEN N/A
  • Revenue
  • PDI N/A
  • RGEN $673,956,000.00
  • Revenue This Year
  • PDI N/A
  • RGEN $14.14
  • Revenue Next Year
  • PDI N/A
  • RGEN $14.32
  • P/E Ratio
  • PDI N/A
  • RGEN N/A
  • Revenue Growth
  • PDI N/A
  • RGEN 8.73
  • 52 Week Low
  • PDI $15.45
  • RGEN $102.97
  • 52 Week High
  • PDI $19.60
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • PDI 56.32
  • RGEN 54.96
  • Support Level
  • PDI $19.06
  • RGEN $111.15
  • Resistance Level
  • PDI $19.38
  • RGEN $127.57
  • Average True Range (ATR)
  • PDI 0.07
  • RGEN 4.80
  • MACD
  • PDI -0.02
  • RGEN 1.31
  • Stochastic Oscillator
  • PDI 45.94
  • RGEN 63.23

About PDI PIMCO Dynamic Income Fund

PIMCO Dynamic Income Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek current income. Its secondary objective is to seek capital appreciation. The fund invests world-wide in a portfolio of debt obligations and other income-producing securities with varying maturities and related derivative instruments. Its investments include mortgage-backed securities, investment grade, and high-yield corporates, corporate and sovereign bonds, other income-producing securities, and related derivative instruments.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: